Tests vertebroplasty added to usual care for painful spine lesions in myeloma
Tests a spine bone procedure plus usual care in adults with myeloma and spine lesions.
Plain-language title generated from the registry record
Registry title: Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.
Key facts
- Where
- Middelfart, DenmarkSee the site
Where in Denmark
- Center for Spine Surgery and ResearchMiddelfart, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Spine Centre of Southern Denmark
- Trial code
- NCT04533217
- Record updated
- 3 December 2024
- Original description
Patients with newly diagnosed or known multiple myeloma with newly diagnosed vertebral lesion(s) will be invited to participate in a cross-sectoral randomized controlled trial. The trial will compare two groups of patients which either receive regular medical treatment of their vertebral lesion(s) or vertebroplasty in addition to regular medical treatment. Our goal is to investigate the effectiveness of vertebroplasty and determine the role of surgical treatment in the overall treatment of patients with multiple myeloma and vertebral lesion(s).Read full original descriptionShow less
Palliative Treatment of Patients With Multiple Myeloma and Painful Vertebral Lesions. A Cross-sectoral Randomized Controlled Trial of Vertebroplasty in Addition to Regular Medical Treatment.
Patients with newly diagnosed or known multiple myeloma with newly diagnosed vertebral lesion(s) will be invited to participate in a cross-sectoral randomized controlled trial. The trial will compare two groups of patients which either receive regular medical treatment of their vertebral lesion(s) or vertebroplasty in addition to regular medical treatment. Our goal is to investigate the effectiveness of vertebroplasty and determine the role of surgical treatment in the overall treatment of patients with multiple myeloma and vertebral lesion(s).
Inclusion: known multiple myeloma; verified lesion(s) between Th6-L5; 4 or less fractures; relevant pain in 3 months or less; vertebroplasty can be performed in one procedure; VAS 5 or more.
Exclusion: psychological or psychiatric disorder hat is expected to interfere with compliance; presence of neurologic deficit.